Causes & What We Know/August 25, 2026/2 min read

Scientists Discover a Common Genetic Link Between Two Autoimmune Diseases

Researchers have identified a shared molecular marker in both Type 1 diabetes and Sjögren's syndrome, suggesting these two autoimmune conditions may operate through similar immune mechanisms. This discovery could eventually help scientists better understand what triggers autoimmune disease.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

causesautoimmunitygeneticsrisk

Key takeaways

A gene called ZBTB16 shows reduced activity in both Type 1 diabetes and primary Sjögren's syndrome, a condition that affects moisture-producing glands
This finding suggests Type 1 diabetes and Sjögren's syndrome may share common immune and metabolic pathways, even though they affect different parts of the body
The discovery was made through analysis of patient gene expression data combined with laboratory validation in mice
Identifying shared biomarkers between autoimmune diseases could improve diagnosis and lead to better understanding of what causes these conditions

What This Research Found

Scientists compared genetic and immune patterns between patients with Type 1 diabetes and patients with primary Sjögren's syndrome—a condition where the immune system attacks the glands that produce tears and saliva. While these diseases affect different body systems, researchers have long suspected they might share underlying immune mechanisms.

Using gene expression databases and advanced analytical methods, researchers identified a gene called ZBTB16 as a shared molecular marker in both conditions. Laboratory tests in mice confirmed that ZBTB16 expression was significantly reduced in blood cells, salivary glands, and pancreatic tissue affected by these autoimmune processes.

Why This Matters

Type 1 diabetes and Sjögren's syndrome are both autoimmune diseases, but they target different tissues and organs. Finding a common genetic signature in both conditions suggests they may operate through similar immune and metabolic processes—even if the consequences look different.

This type of discovery helps scientists build a more complete picture of how autoimmune disease develops. By understanding shared pathways, researchers may eventually develop better diagnostic tools and therapeutic approaches that work across multiple autoimmune conditions.

What's Next

This research represents an early-stage finding that identifies a potential biomarker. Further research will be needed to determine whether ZBTB16 could be used clinically to diagnose or predict autoimmune disease, or whether manipulating this gene might help prevent or treat these conditions.

The identification of ZBTB16 and its role in immune and metabolic dysfunction opens new directions for understanding how autoimmune diseases develop. As research continues, findings like these contribute to the broader scientific effort to prevent Type 1 diabetes and improve outcomes for people living with autoimmune conditions.

Evidence label

Source: Frontiers in immunology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.